Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Samer A. Srour
Novel Chemotherapy-Free Combination Regimen for Ibrutinib-Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
Related publications
Ibrutinib Plus Palbociclib Has Efficacy in Mantle Cell Lymphoma
Cancer Discovery
Oncology
BTK Inhibitor Ibrutinib in CLL and Mantle Cell Lymphoma
Community Oncology
Expanding Horizons in the Treatment of Mantle Cell Lymphoma: Ibrutinib a Novel BTK-targeting Inhibitor
International Journal of Basic & Clinical Pharmacology
Venetoclax as a Single Agent and in Combination With PI3K-MTOR1/2 Kinase Inhibitors Against Ibrutinib Sensitive and Resistant Mantle Cell Lymphoma
British Journal of Haematology
Hematology
Polo-Like Kinase 1: A Novel Target for the Treatment of Therapy-Resistant Mantle Cell Lymphoma
Lymphoma
Effects of the Proteasome Inhibitor Bortezomib in Combination With Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-Analysis
Turkish Journal of Haematology
Hematology
Smart Start: Rituximab, Lenalidomide, and Ibrutinib Alone Prior to Combination With Chemotherapy for Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Long-Term Outcomes and Mutation Profiling of Patients With Mantle Cell Lymphoma (MCL) Who Discontinued Ibrutinib
British Journal of Haematology
Hematology
Treatment of Resistant Mantle Cell Lymphoma With Allogeneic Bone Marrow Transplantation
Bone Marrow Transplantation
Transplantation
Hematology
